Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,716 | -52,599 | -37,059 | -21,255 | -10,408 |
| Depreciation Amortization | N/A | N/A | 14,373 | N/A | N/A |
| Accounts payable and accrued liabilities | 305 | N/A | N/A | -2,595 | -1,318 |
| Other Working Capital | 3,569 | -2,364 | 301 | -726 | -701 |
| Other Operating Activity | 2,533 | 19,163 | 0 | 11,346 | 5,460 |
| Operating Cash Flow | $-9,309 | $-35,800 | $-22,385 | $-13,230 | $-6,967 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30 | 23,216 | 23,216 | 23,841 | 23,216 |
| Other Financing Activity | 30,469 | 15,298 | 3,687 | 0 | 347 |
| Financing Cash Flow | $30,499 | $38,514 | $26,903 | $23,841 | $23,563 |
| Beginning Cash Position | 97,565 | 94,851 | 94,851 | 94,851 | 94,851 |
| End Cash Position | 118,755 | 97,565 | 99,369 | 105,462 | 111,447 |
| Net Cash Flow | $21,190 | $2,714 | $4,518 | $10,611 | $16,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,309 | -35,800 | -22,385 | -13,230 | -6,967 |
| Free Cash Flow | -9,309 | -35,800 | -22,385 | -13,230 | -6,967 |